L Godny1, L Reshef2, T Pfeffer-Gik1, I Goren1, H Yanai1, H Tulchinsky3, U Gophna2, I Dotan4. 1. Division of Gastroenterology, Rabin Medical Center (affiliated to the Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel), Petah-Tikva, Israel. 2. Department of Molecular Microbiology and Biotechnology, George S. Wise Faculty of Life Sciences, Tel Aviv University, Tel Aviv, Israel. 3. Proctology Unit, Department of Surgery, Tel Aviv Sourasky Medical Center (affiliated to Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel), Tel Aviv, Israel. 4. Division of Gastroenterology, Rabin Medical Center (affiliated to the Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel), Petah-Tikva, Israel. irisdo@clalit.org.il.
Abstract
BACKGROUND: Mediterranean diet (MED) is associated with health benefits, yet scarce data exist regarding the role of MED in inflammatory bowel diseases (IBD). Herein, we aimed to evaluate the association between MED and inflammatory markers in patients with IBD after pouch surgery. METHODS: Consecutive patients after pouch surgery due to ulcerative colitis (UC) were recruited at a comprehensive pouch clinic. Adherence to MED was calculated according to MED score, ranging from 0 (low adherence) to 9 (high adherence), based on food-frequency questionnaires. Pouch behavior was defined as normal pouch (NP) or pouchitis based on Pouchitis Disease Activity Index (PDAI) and disease activity was defined as active or inactive. C-reactive protein (CRP) and fecal calprotectin were assessed. RESULTS: Overall 153 patients were enrolled (male gender 47%; mean age 46 ± 14 years; mean pouch age 9.5 ± 7 years). MED scores were higher in patients with normal vs. elevated CRP and calprotectin levels (4.6 ± 1.8 vs. 4.4 ± 1.6, p = 0.28; 4.8 ± 1.8 vs. 4.07 ± 1.7, p < 0.05, respectively). In a multivariate regression, MED score was associated with decreased calprotectin levels (OR = 0.74 [0.56-0.99]). Adherence to MED was associated with dietary fiber and antioxidants intake. Finally, in a subgroup of patients with NP followed up for 8 years, higher adherence to MED trended to be inversely associated with the onset of pouchitis (log rank = 0.17). CONCLUSIONS: In patients with UC after pouch surgery, adherence to MED is associated with decreased calprotectin levels. Thus, MED may have a role in modifying intestinal inflammation in IBD.
BACKGROUND: Mediterranean diet (MED) is associated with health benefits, yet scarce data exist regarding the role of MED in inflammatory bowel diseases (IBD). Herein, we aimed to evaluate the association between MED and inflammatory markers in patients with IBD after pouch surgery. METHODS: Consecutive patients after pouch surgery due to ulcerative colitis (UC) were recruited at a comprehensive pouch clinic. Adherence to MED was calculated according to MED score, ranging from 0 (low adherence) to 9 (high adherence), based on food-frequency questionnaires. Pouch behavior was defined as normal pouch (NP) or pouchitis based on Pouchitis Disease Activity Index (PDAI) and disease activity was defined as active or inactive. C-reactive protein (CRP) and fecal calprotectin were assessed. RESULTS: Overall 153 patients were enrolled (male gender 47%; mean age 46 ± 14 years; mean pouch age 9.5 ± 7 years). MED scores were higher in patients with normal vs. elevated CRP and calprotectin levels (4.6 ± 1.8 vs. 4.4 ± 1.6, p = 0.28; 4.8 ± 1.8 vs. 4.07 ± 1.7, p < 0.05, respectively). In a multivariate regression, MED score was associated with decreased calprotectin levels (OR = 0.74 [0.56-0.99]). Adherence to MED was associated with dietary fiber and antioxidants intake. Finally, in a subgroup of patients with NP followed up for 8 years, higher adherence to MED trended to be inversely associated with the onset of pouchitis (log rank = 0.17). CONCLUSIONS: In patients with UC after pouch surgery, adherence to MED is associated with decreased calprotectin levels. Thus, MED may have a role in modifying intestinal inflammation in IBD.
Authors: Dale Lee; Lindsey Albenberg; Charlene Compher; Robert Baldassano; David Piccoli; James D Lewis; Gary D Wu Journal: Gastroenterology Date: 2015-01-15 Impact factor: 22.682
Authors: Margarita Martinez-Medina; Jérémy Denizot; Nicolas Dreux; Frédéric Robin; Elisabeth Billard; Richard Bonnet; Arlette Darfeuille-Michaud; Nicolas Barnich Journal: Gut Date: 2013-04-18 Impact factor: 23.059
Authors: Jorrit L Opstelten; Max Leenders; Vincent K Dik; Simon S M Chan; Fiona D M van Schaik; Kay-Tee Khaw; Robert Luben; Göran Hallmans; Pontus Karling; Stefan Lindgren; Olof Grip; Timothy J Key; Francesca L Crowe; Heiner Boeing; Manuela M Bergmann; Kim Overvad; Domenico Palli; Giovanna Masala; Antoine Racine; Franck Carbonnel; Marie-Christine Boutron-Ruault; Anne Tjønneland; Anja Olsen; Vibeke Andersen; Rudolf Kaaks; Verena A Katzke; Rosario Tumino; Antonia Trichopoulou; Peter D Siersema; H Bas Bueno-de-Mesquita; Andrew R Hart; Bas Oldenburg Journal: Inflamm Bowel Dis Date: 2016-06 Impact factor: 5.325
Authors: Siew C Ng; Hai Yun Shi; Nima Hamidi; Fox E Underwood; Whitney Tang; Eric I Benchimol; Remo Panaccione; Subrata Ghosh; Justin C Y Wu; Francis K L Chan; Joseph J Y Sung; Gilaad G Kaplan Journal: Lancet Date: 2017-10-16 Impact factor: 79.321
Authors: Benoit Chassaing; Omry Koren; Julia K Goodrich; Angela C Poole; Shanthi Srinivasan; Ruth E Ley; Andrew T Gewirtz Journal: Nature Date: 2015-02-25 Impact factor: 49.962
Authors: Jessica A Fitzpatrick; Sarah L Melton; Chu Kion Yao; Peter R Gibson; Emma P Halmos Journal: Nat Rev Gastroenterol Hepatol Date: 2022-05-16 Impact factor: 73.082